One example is Mdivi-1, a Drp-1 inhibitor that showed protective effects by mitigating mitochondrial dysfunction and synaptic impairment in HD [242] and by improving mitochondrial morphology and survival in ALS mouse models [243]. This evidence concerns the gene DNM1L and Huntington disease.